It seems like every few weeks, there’s a new “miracle fix” for anxiety trending on social media. The latest is a decades-old heart medication that more and more people are saying helps them stay calm ...

New Zealand health officials announced Wednesday that new prescriptions for puberty blockers will no longer be issued to children identifying as transgender. Doctors will stop prescribing the ...

Justin Pot is a freelance journalist who helps people get more out of technology. November 21, 2025 Add as a preferred source on Google Add as a preferred source on Google Want to block ads on your ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet The ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the company's first office ...

For 40 years, it has been the standard in post-heart attack health care, but a new study from the European Society of Cardiology is putting the usage of beta blockers in limbo. While the new study may ...

Doctors at a gender clinic in California doled out puberty blockers to kids as young as 9 — despite reportedly admitting behind the scenes that some research backing gender-affirming care for children ...

Samsung is testing a new setting in One UI 8.5 that allows temporarily disabling the Auto Blocker feature. Users can choose to allow Auto Blocker to automatically re-enable itself after 30 minutes of ...

Individuals who are simultaneously taking certain antidepressants and beta blockers had a decrease in systolic blood pressure (BP) and an increase in their risk for bradycardia, according to new data ...

Beta blockers are quickly becoming the hot new drug to combat anxiety. The medication, also known as propranolol, was approved by the U.S. Food and Drug Administration in 1967 for the treatment of ...

Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...